These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 11432346

  • 1. [Multi-institutional cooperative study on combination chemotherapy with THP, CDDP and 5-FU for squamous cell carcinoma of the head and neck].
    Urade M, Yanagisawa T, Kishimoto H, Yoshioka W, Teranobu O, Shigeta Y, Komori T, Shimada K, Ohnishi M, Tanaka Y, Kamiya Y, Akazawa N, Oko T, Takahashi N, Adachi R, Tanigaki S, Hirata Y, Yakushiji N, Kitamura R, Hashikawa N, Hyogo Oncology Group for Oromaxillary Tumors.
    Gan To Kagaku Ryoho; 2001 Jun; 28(6):789-95. PubMed ID: 11432346
    [Abstract] [Full Text] [Related]

  • 2. [Low-dose CDDP and 5-FU for head and neck cancer patients].
    Fujii M, Kanke M, Tomita T.
    Gan To Kagaku Ryoho; 1999 Oct; 26(11):1542-7. PubMed ID: 10553410
    [Abstract] [Full Text] [Related]

  • 3. The role of low dose cisplatin plus 5-fluorouracil for treatment of recurrent and/or advanced squamous cell carcinoma of the head and neck.
    Kohno N, Kitahara S, Tamura E, Tanabe T, Nakanoboh M, Kawada M, Shirasaka T.
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():592-9. PubMed ID: 10895216
    [Abstract] [Full Text] [Related]

  • 4. [Combination chemotherapy with 5-FU and CDDP or CDDP analog for head and neck cancer].
    Fujii M, Ohno Y, Tokumaru Y, Imanishi Y, Kanke M.
    Gan To Kagaku Ryoho; 1996 Nov; 23(13):1740-6. PubMed ID: 8937483
    [Abstract] [Full Text] [Related]

  • 5. Salvage chemotherapy with PEM and long-CF regimen in CDDP refractory advanced head and neck cancer.
    Kohno N, Ichikawa G, Shirasaka T, Inuyama Y, Kawaida M, Ohnuma T.
    Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():209-14. PubMed ID: 7661582
    [Abstract] [Full Text] [Related]

  • 6. Analysis of efficacy and toxicity of chemotherapy with cisplatin, 5-fluorouracil, methotrexate and leucovorin (PFML) and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck.
    Katori H, Tsukuda M, Taguchi T.
    Cancer Chemother Pharmacol; 2007 May; 59(6):789-94. PubMed ID: 17053926
    [Abstract] [Full Text] [Related]

  • 7. Phase II trial of dose-dense paclitaxel, cisplatin, 5-fluorouracil, and leucovorin with filgrastim support in patients with squamous cell carcinoma of the head and neck.
    Hitt R, Jimeno A, Millán JM, Castellano D, Cortés-Funes H.
    Cancer; 2004 Aug 15; 101(4):768-75. PubMed ID: 15305408
    [Abstract] [Full Text] [Related]

  • 8. [Effect of combination chemotherapy with nedaplatin and 5-FU for head and neck squamous cell carcinoma].
    Yamaoka H, Tsukuda M, Enomoto H, Kawai S, Mikami Y, Arai Y, Nagahara T, Mochimatsu I.
    Gan To Kagaku Ryoho; 2001 Sep 15; 28(9):1245-9. PubMed ID: 11579634
    [Abstract] [Full Text] [Related]

  • 9. [Combined CDDP-THP-PEP chemotherapy (PTP therapy) for head and neck squamous cell carcinoma--a group study].
    Sugasawa M, Nibu K, Ichimura K, Kaga K, Asai M, Senba T, Yamasoba T, Tsunoda K, Abe K, Kobayashi T.
    Gan To Kagaku Ryoho; 1994 Jun 15; 21(7):969-74. PubMed ID: 8002635
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology Group.
    Gibson MK, Li Y, Murphy B, Hussain MH, DeConti RC, Ensley J, Forastiere AA, Eastern Cooperative Oncology Group.
    J Clin Oncol; 2005 May 20; 23(15):3562-7. PubMed ID: 15908667
    [Abstract] [Full Text] [Related]

  • 13. Systemic chemotherapy with cisplatin plus 5-FU (PF) for recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): efficacy and safety of a lower dose of PF (80/800) at a single institution in Japan.
    Kiyota N, Tahara M, Kadowaki S, Fuse N, Doi T, Minami H, Ohtsu A.
    Jpn J Clin Oncol; 2009 Apr 20; 39(4):225-30. PubMed ID: 19211574
    [Abstract] [Full Text] [Related]

  • 14. [Combination chemotherapy with nedaplatin and 5-FU for head and neck cancer].
    Fujii M, Tokumaru Y, Imanishi Y, Kanke M, Kanzaki J, Ohno Y.
    Gan To Kagaku Ryoho; 1998 Jan 20; 25(1):53-8. PubMed ID: 9464329
    [Abstract] [Full Text] [Related]

  • 15. A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group study 0007.
    Worden FP, Moon J, Samlowski W, Clark JI, Dakhil SR, Williamson S, Urba SG, Ensley J, Hussain MH, Southwest Oncology Group, Head and Neck Working Group.
    Cancer; 2006 Jul 15; 107(2):319-27. PubMed ID: 16779801
    [Abstract] [Full Text] [Related]

  • 16. Induction chemotherapy with S-1 plus cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck.
    Choi YJ, Chung JS, Shin HJ, Cho GJ, Wang SG, Lee BJ, Cho BM, Joo YD, Sohn CH.
    J Laryngol Otol; 2008 Aug 15; 122(8):848-53. PubMed ID: 18047761
    [Abstract] [Full Text] [Related]

  • 17. Weekly cisplatin paclitaxel and continuous infusion fluorouracil in patients with recurrent and/or metastatic head and neck squamous cell carcinoma: a phase II study.
    Schena M, Barone C, Birocco N, Dongiovanni D, Numico G, Colantonio I, Bertetto O.
    Cancer Chemother Pharmacol; 2005 Mar 15; 55(3):271-6. PubMed ID: 15592837
    [Abstract] [Full Text] [Related]

  • 18. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
    Psyrri A, Kwong M, DiStasio S, Lekakis L, Kassar M, Sasaki C, Wilson LD, Haffty BG, Son YH, Ross DA, Weinberger PM, Chung GG, Zelterman D, Burtness BA, Cooper DL.
    J Clin Oncol; 2004 Aug 01; 22(15):3061-9. PubMed ID: 15284256
    [Abstract] [Full Text] [Related]

  • 19. Paclitaxel, cisplatin and 5-fluorouracil in recurrent squamous cell carcinoma of the head and neck: a phase II trial from an Italian cooperative group.
    Benasso M, Ponzanelli A, Merlano M, Numico G, Ricci I, Vigo V, Grossi F, Amadori D, Cavallo G, Capaccetti B, Taveggia P, Boni L, Rosso R.
    Acta Oncol; 2006 Aug 01; 45(2):168-74. PubMed ID: 16546862
    [Abstract] [Full Text] [Related]

  • 20. A phase II trial of docetaxel, cisplatin and 5-fluorouracil in patients with recurrent squamous cell carcinoma of the head and neck (SCCHN).
    Baghi M, Hambek M, Wagenblast J, May A, Gstoettner W, Knecht R.
    Anticancer Res; 2006 Aug 01; 26(1B):585-90. PubMed ID: 16739325
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.